VDRM
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2024 Q3 | -0.00 | $150,189 | -$874,840 |
| 2024 Q2 | 0.00 | $150,131 | — |
| 2024 Q1 | 0.00 | $150,490 | $367,658 |
| 2023 Q4 | 0.00 | $150,065 | $370 |
| 2023 Q3 | 0.00 | $150,203 | -$30 |
| 2023 Q2 | -0.00 | $150,105 | -$30 |
| 2023 Q1 | 0.00 | $150,125 | -$135 |
| 2022 Q4 | -0.00 | $135,648 | -$30 |